What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...

New weight-loss jabs could help boost the economy in Britain by getting people “back into work”, the Prime Minister has said.

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

I don’t think suddenly we’ve got X amount of unemployed people and we all give them Mounjaro and once they start losing ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...

A woman who takes weight loss medication has called Health Secretary ... Lilly will examine the “real-world effectiveness” of anti-obesity treatment Mounjaro, also known as tirzepatide ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

Goldman Sachs Research predicts the global anti-obesity drug market could reach $100 billion by ... a whopping 66% of ...

Noom Med with SmartRx, in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit ...

“A lot of insurance companies do not cover anti-obesity medication. That’s the big deal. We don’t have access,” said Apovian. At her clinic, Barenbaum describes prescribing some GLP-1s off ...

Additionally, the research will explore if the medication can decrease unemployment ... pick up the tab for unhealthy lifestyles". Anti-obesity drugs are generally prescribed alongside advice ...